This current large scale prospective study, (Trial in AKI using NGAL and Fluid Overload to optimize CRRT Use, TAKING FOCUS 2) evaluate the feasibility and accuracy of a sequential risk-assessment for AKI prediction in critically ill children using the RAI, urine NGAL and the FST. The gene discussed is LCN2; the disease is acute kidney injury.